Successful treatment of refractory gastrointestinal bleeding by systemic (oral) ankaferd blood stopper in a patient with glanzmann thrombasthenia

Abstract

Background: Glanzmann Thrombasthenia (GT) is agenetic platelet dysfunction and a life threatening dis- ease. Ankaferd Blood Stopper (ABS) is a topical he- mostatic agent of herbal origin which has been recentlymade available for clinical use. Its hemostatic effect isindependent from blood clotting factors and occurs as aresult of the aggregation of focal red blood cells by anencapsulated protein web. Case Report: In this paper, a patient with GT is pre- sented in whom 3 months of gastrointestinal bleeding refractory to all medical therapies was controlled with-in a short time of using oral ABS.Conclusion: The difference between this patient andother cases presented in the medical literature is the oraluse of ABS. Thus, this patient may contribute to the medi-cal community in showing the safety and efficacy of sys-temic (oral) ABS in patients with disorders of coagulation.However, there is a need for more patient experiences.